Historical record - last NADAC effective date: 6/23/2021
Product Information
ACID REDUCER 10 MG TABLET is a generic product labeled by Topco Associates LLC, priced at $0.0994 per EA under NDC 36800014165. Its NADAC has been published 397 times since Nov 28, 2013.
FDA first approved this application on Mar 18, 2005.
Strength
10 mg/1
Manufacturer
Topco Associates LLCNDC
36800014165
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
6/23/2021
Active Ingredients
FAMOTIDINEApproval Type
Generic (ANDA)
FDA Application
ANDA075400FDA Approved
3/18/2005
On Market Since
9/11/2009
Pharmacological Classes
Price Statistics
The NADAC for ACID REDUCER 10 MG TABLET has been published 397 times since Nov 28, 2013, and over the history we have for it it has risen 11.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0994 per EA |
|---|---|
| All-time high | $0.1293 (Jul 15, 2015) |
| All-time low | $0.0878 (Jan 22, 2014) |
| Median price | $0.1131 |
| Average price | $0.1121 |
| Largest weekly change | +25.0% (Apr 22, 2015) |
| Weeks tracked | 397 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
+11.7%
Last surveyed Jun 30, 2021 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 8 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 7% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Topco Associates LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Famotidine market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Histamine-2 Receptor Antagonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ACID REDUCER 10 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ACID REDUCER 10 MG TABLET, manufactured by Topco Associates LLC, is $0.0994 per EA (NDC 36800014165), effective Jun 30, 2021.
How has the price of ACID REDUCER 10 MG TABLET changed over time?
Over the history we have for it, the NADAC for ACID REDUCER 10 MG TABLET has risen 11.7%. It has been tracked across 397 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for ACID REDUCER 10 MG TABLET?
Since Nov 28, 2013, the NADAC for ACID REDUCER 10 MG TABLET has ranged from a low of $0.0878 (Jan 22, 2014) to a high of $0.1293 (Jul 15, 2015), with a median of $0.1131 per EA.
Are there cheaper alternatives to ACID REDUCER 10 MG TABLET?
Yes. 8 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ACID REDUCER 10 MG TABLET, is $0.0923 per EA — about 7% below ACID REDUCER 10 MG TABLET.
Who manufactures ACID REDUCER 10 MG TABLET?
ACID REDUCER 10 MG TABLET (NDC 36800014165) is labeled by Topco Associates LLC, and CMS classifies it as a generic product.